Nutrien (NYSE:NTR) Price Target Cut to $60.00

Nutrien (NYSE:NTR) had its price target decreased by equities research analysts at Royal Bank of Canada from $70.00 to $60.00 in a research report issued on Monday, MarketBeat Ratings reports. The firm currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective points to a potential upside of 17.83% from the stock’s current price.

Several other research analysts have also commented on the company. Wells Fargo & Company boosted their price target on Nutrien from $67.00 to $68.00 and gave the stock an “overweight” rating in a research report on Friday, May 10th. Berenberg Bank upgraded Nutrien from a “hold” rating to a “buy” rating and boosted their target price for the stock from $60.00 to $66.00 in a research note on Monday, April 29th. Mizuho boosted their target price on Nutrien from $54.00 to $56.00 and gave the stock an “underweight” rating in a research note on Friday, May 17th. UBS Group dropped their target price on Nutrien from $67.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, July 9th. Finally, Scotiabank dropped their target price on Nutrien from $67.00 to $66.00 and set an “outperform” rating on the stock in a research note on Monday, May 13th. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, Nutrien currently has a consensus rating of “Moderate Buy” and a consensus price target of $65.63.

Nutrien Trading Up 1.8 %

NTR opened at $50.92 on Monday. The firm has a market cap of $25.19 billion, a price-to-earnings ratio of 29.78, a PEG ratio of 1.62 and a beta of 0.83. The company has a current ratio of 1.15, a quick ratio of 0.53 and a debt-to-equity ratio of 0.36. Nutrien has a 12 month low of $47.86 and a 12 month high of $69.12. The stock has a fifty day moving average price of $54.14 and a 200-day moving average price of $53.17.

Nutrien (NYSE:NTR) last released its quarterly earnings results on Wednesday, May 8th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.34 by $0.11. The firm had revenue of $5.39 billion during the quarter, compared to analyst estimates of $5.38 billion. Nutrien had a return on equity of 7.31% and a net margin of 3.01%. As a group, equities research analysts anticipate that Nutrien will post 3.84 earnings per share for the current fiscal year.

Institutional Trading of Nutrien

Hedge funds and other institutional investors have recently bought and sold shares of the stock. International Assets Investment Management LLC acquired a new stake in Nutrien during the fourth quarter worth about $3,433,000. Vanguard Group Inc. lifted its position in shares of Nutrien by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 18,210,375 shares of the company’s stock valued at $1,025,790,000 after acquiring an additional 158,161 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Nutrien by 370.1% in the first quarter. SG Americas Securities LLC now owns 58,041 shares of the company’s stock valued at $3,152,000 after acquiring an additional 45,695 shares in the last quarter. Wellington Management Group LLP lifted its position in shares of Nutrien by 54.3% in the fourth quarter. Wellington Management Group LLP now owns 841,144 shares of the company’s stock valued at $47,620,000 after acquiring an additional 296,122 shares in the last quarter. Finally, BNP Paribas purchased a new position in Nutrien during the first quarter worth approximately $1,146,000. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.